The therapeutic effect of Huoxuexiaozhi capsule on SOD, MDA and CYP450 in treating fatty liver disease
-
摘要: 目的 观察中藏药活血消脂胶囊对脂肪肝的疗效及对血清超氧化物歧化酶(SOD)及丙二醛(MDA)、细胞色素P450(CYP450)的影响,并探讨其作用机制。 方法 采用前瞻性随机对照研究方法,选择2014-2016年青海大学附属医院确诊的脂肪肝患者100例,采用随机数字表法将患者分为治疗组和对照组,2组各50例,治疗组患者口服活血消脂胶囊,4粒/次,3次/d;对照组患者口服东宝甘泰(复方蛋氨酸胆碱)片,3片/次,3次/d。5周为一疗程。疗程结束后观察临床疗效。观察2组的症状、肝功能指标及血清SOD及MDA、CYP450的变化并进行分析研究。 结果 治疗组临床治愈14例,显效18例,好转12例,无效6例,总有效率为88.0%,对照组临床治愈7例,显效11例,好转18例,无效14例,总有效率为72.0%,2组比较差异有统计学意义(P<0.01);与对照组比较,活血消脂胶囊能显著改善脂肪肝患者食欲不振、脘腹胀满、胁肋胀痛、恶心呕吐、便溏、乏力等临床症状,差异有统计学意义(均P<0.05);与对照组比较,活血消脂胶囊能显著改善脂肪肝患者血ALP、ALT、AST及γ-GT水平,差异有统计学意义(均P<0.01);活血消脂胶囊能显著升高脂肪肝患者血清SOD水平,降低MDA及 CYP450水平,2组治疗后比较,差异有统计学意义(均P<0.01)。 结论 活血消脂胶囊能治疗脂肪肝,改善临床症状,改善肝功能,升高血清SOD、降低MDA及CYP450,其作用明显优于东宝甘泰片。Abstract: Objective To observe the therapeutic effect of traditional Chinese medicine decoction Huoxuexiaozhi capsule on Fatty liver diseases superoxide dismutase (SOD), malondialdehyde (MDA), Cytochrome P450 (CYP450) in blood serum, and approach its mechanism. Methods A prospective randomized controlled study was conducted, including 100 patients who were definitely diagnosed as fatty liver and admitted into affiliated Qinghai University Hospital from January 2014 to December 2016, and they were divided into a treatment group and a control group, 50 cases in each group by random number table method. Traditional Chinese medicine Huoxuexiaozhi capsule was taken orally in treatment group, 4 capsules each time, three times each day, and Dongbaogantai tablet was taken orally in control group, 3 Tablets each time, three times each day. One course of treatment was five weeks.After treatment, the clinic effect was analysed.the changes of patients symptoms, liver function, SOD, MDA, CYP450 in blood serum were studied and analysed. Results Fourteen cases were cured, 18 cases were significantly effective, 12 cases improved and 6 cases were null and void in treatment group, the totol effective rate is 88.0%. Seven cases were cured, 11 cases were significantly effective, 18 cases improved and 14 cases were nulland void in treatment group, the totol effective rate is 72.0%. And there were statistical significant between two groups (P<0.01). Huoxuexiaozhi capsule improved symptoms significantly of fatty liver diseases, such as loss of appetite, often loose stools weak, abdominal distension full side rib pain, nausea and vomiting, there were statistical significant between two groups (all P<0.05). Huoxuexiaozhi capsule improved ALT, AST, γ-GT and ALP, there were statistical significant between two groups (all P<0.01). Huoxuexiaozhi capsule increased SOD, redused MDA and CYP450, there were statistical significant between two groups after treatment (all P<0.01). Conclusion Huoxuexiaozhi capsule can treat fatty liver disease, improve symptoms, liver function, increase SOD, decrease MDA and CYP450, its effect is better than Dongbaogantai tablet (all P<0.01).
-
Key words:
- Fatty liver diseases /
- Huoxuexiaozhi capsule /
- SOD /
- MDA /
- CYP450 in blood serum
点击查看大图
计量
- 文章访问数: 222
- HTML全文浏览量: 39
- PDF下载量: 0
- 被引次数: 0